Difference between revisions of "William A. Haseltine"

From Wikispooks
Jump to navigation Jump to search
m
 
Line 1: Line 1:
 
{{person
 
{{person
|name=Dr William Haseltine
+
|name=Dr Bill Haseltine
 
|constitutes=scientist, businessman, author
 
|constitutes=scientist, businessman, author
 
|twitter=https://twitter.com/WmHaseltine
 
|twitter=https://twitter.com/WmHaseltine
Line 9: Line 9:
 
|birth_place=St. Louis, Missouri
 
|birth_place=St. Louis, Missouri
 
|alma_mater=University of California Berkeley,Harvard University,Massachusetts Institute of Technology
 
|alma_mater=University of California Berkeley,Harvard University,Massachusetts Institute of Technology
 +
|employment={{job
 +
|title=Human Genome Sciences/CEO
 +
|start=1993
 +
|end=2004
 
}}
 
}}
'''William A. Haseltine''' (born 17 October 1944) is an [[United States|American]] scientist, businessman, author, and philanthropist who is known for his groundbreaking work on [[HIV]]/[[AIDS]] and the human genome.<ref>''[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC431041/ "Terminal redundancy and the origin of replication of Rous sarcoma virus RNA"]''</ref> Dr William Haseltine was a professor at [[Harvard Medical School]] where he founded two research departments on [[cancer]] and [[HIV]]/[[AIDS]].
+
}}
 +
'''William A. Haseltine''' (born 17 October 1944) is an [[United States|American]] scientist, businessman, author, and philanthropist who is known for his groundbreaking work on [[HIV]]/[[AIDS]] and the human genome.<ref>''[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC431041/ "Terminal redundancy and the origin of replication of Rous sarcoma virus RNA"]''</ref> Dr [[Bill Haseltine]] was a professor at [[Harvard Medical School]] where he founded two research departments on [[cancer]] and [[HIV]]/[[AIDS]].
  
 
==Businessman==
 
==Businessman==
[[Dr Haseltine]] established a number of biotechnology companies including Cambridge Biosciences, the Virus Research Institute, ProScript, LeukoSite, Dendreon, Diversa, X-VAX, and Demetrix. He was a founder chairman and CEO of [[Human Genome Sciences]], a company that pioneered the application of genomics to drug discovery.
+
[[Bill Haseltine]] established a number of biotechnology companies including Cambridge Biosciences, the Virus Research Institute, ProScript, LeukoSite, Dendreon, Diversa, X-VAX, and Demetrix. He was a founder chairman and CEO of [[Human Genome Sciences]], a company that pioneered the application of genomics to drug discovery.
  
 
==Philanthropist==
 
==Philanthropist==
Dr Haseltine is the president of the [[Haseltine Foundation for Science and the Arts]] and is the founder, chairman, and president of ACCESS Health International, a not-for-profit organisation dedicated to improving access to high-quality health worldwide. He was listed by ''[[Time Magazine]]'' as one of the world's 25 most influential business people in 2001 and one of the 100 most influential leaders in biotechnology by [[Scientific American]] in 2015.
+
Dr Bill Haseltine is the president of the [[Haseltine Foundation for Science and the Arts]] and is the founder, chairman, and president of ACCESS Health International, a not-for-profit organisation dedicated to improving access to high-quality health worldwide. He was listed by ''[[Time Magazine]]'' as one of the world's 25 most influential business people in 2001 and one of the 100 most influential leaders in biotechnology by [[Scientific American]] in 2015.
  
 
==On coronavirus==
 
==On coronavirus==
In April 2020, Dr Haseltine was interviewed on [[Fox News]] and said that [https://en.wikipedia.org/wiki/Antiserum convalescent antiserum] is likely to provide the best protection against [[COVID-19]].<ref>''[https://www.foxnews.com/opinion/coronavirus-beyond-flattening-curve-end-pandemic-william-haseltine "Dr William Haseltine: Coronavirus – Beyond flattening the curve, here's how to end the pandemic"]''</ref>
+
In April 2020, [[Dr Haseltine]] was interviewed on [[Fox News]] and said that [https://en.wikipedia.org/wiki/Antiserum convalescent antiserum] is likely to provide the best protection against [[COVID-19]].<ref>''[https://www.foxnews.com/opinion/coronavirus-beyond-flattening-curve-end-pandemic-william-haseltine "Dr William Haseltine: Coronavirus – Beyond flattening the curve, here's how to end the pandemic"]''</ref>
  
 
On 16 May 2020 Dr Haseltine raised doubts about the effectiveness of the [[Oxford Vaccine Group]] vaccine, telling ''Forbes'' magazine:
 
On 16 May 2020 Dr Haseltine raised doubts about the effectiveness of the [[Oxford Vaccine Group]] vaccine, telling ''Forbes'' magazine:

Latest revision as of 13:29, 23 May 2020

Person.png Dr Bill Haseltine   TwitterRdf-entity.pngRdf-icon.png
(scientist, businessman, author)
Dr Haseltine.jpg
Born17 October 1944
St. Louis, Missouri
Alma materUniversity of California Berkeley, Harvard University, Massachusetts Institute of Technology
Member ofCouncil on Foreign Relations/Members

William A. Haseltine (born 17 October 1944) is an American scientist, businessman, author, and philanthropist who is known for his groundbreaking work on HIV/AIDS and the human genome.[1] Dr Bill Haseltine was a professor at Harvard Medical School where he founded two research departments on cancer and HIV/AIDS.

Businessman

Bill Haseltine established a number of biotechnology companies including Cambridge Biosciences, the Virus Research Institute, ProScript, LeukoSite, Dendreon, Diversa, X-VAX, and Demetrix. He was a founder chairman and CEO of Human Genome Sciences, a company that pioneered the application of genomics to drug discovery.

Philanthropist

Dr Bill Haseltine is the president of the Haseltine Foundation for Science and the Arts and is the founder, chairman, and president of ACCESS Health International, a not-for-profit organisation dedicated to improving access to high-quality health worldwide. He was listed by Time Magazine as one of the world's 25 most influential business people in 2001 and one of the 100 most influential leaders in biotechnology by Scientific American in 2015.

On coronavirus

In April 2020, Dr Haseltine was interviewed on Fox News and said that convalescent antiserum is likely to provide the best protection against COVID-19.[2]

On 16 May 2020 Dr Haseltine raised doubts about the effectiveness of the Oxford Vaccine Group vaccine, telling Forbes magazine:

"The day after data appeared from the vaccine maker Sinovac showed complete protection of rhesus monkeys by their vaccine candidate (whole inactivated SARS-CoV-2 virus particles), scientists from the Jenner Institute in Oxford issued a press release announcing that their vaccine (an adenovirus vector based vaccine that carried the SARS-CoV-2 spike protein) worked to protect rhesus monkeys and that they were moving forward with large scale human safety trials. At the time, the substantiating data was not available. Now it is, in the form of a May 13 BioRxiv preprint.

"What to make of this data? It is crystal clear that the vaccine did not provide sterilising immunity to the virus challenge, the gold standard for any vaccine. It may provide partial protection. The question then becomes: Will partial protection be enough to control the COVID-19 pandemic? That is an open question.

"We know what the public response is of the OVG and their collaborators. Proceed with full speed to human safety then efficacy trials. Time will tell if this is the best approach. I wouldn’t bet on it."[3]

On 24 May 2020, Dr Haseltine tweeted:

"Trust in science is being undermined as companies rush to announce breakthroughs without sharing the data behind their findings. Despite the need to find solutions to this pandemic, we cannot give up our standards in the scientific and medical community."[4]


References

Wikipedia.png This page imported content from Wikipedia on 22 May 2020.
Wikipedia is not affiliated with Wikispooks.   Original page source here